LEXICON
No.130 April 17, 2013

Medical incident; close-call incident; near-miss incident
ヒヤリ・ハット
Medical accident
医療事故
Medical malpractice; medical error; medical negligence
医療過誤、医療ミス
Japan Council for Quality Health Care
日本医療機能評価機構
Medical lawsuit
医療訴訟
No-fault compensation system
無過失補償制度

According to Heinrich’s Law, “for every accident that causes a major injury, there are 29 accidents that cause minor injuries and 300 accidents that cause no injuries.” This law is depicted as Heinrich’s pyramid with a major accident on top,...

To read the full story

LEXICON

By Philip Carrigan

The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…

By Shinya Sato

Following the launch of two new therapies since last year, Japan has seen fresh moves in drug development for amyotrophic…

The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…

Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…

By Ken Yoshino

Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…

For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…

A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…

The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…

Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…

By Yoshinori Sagehashi

The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…